Emergency Agitation in T&A

• Status: Completed
• Trial end date: 2010-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Sevoflurane has been used commonly in pediatric anesthesia since 1990. However, it has caused more emergency agitation (EA) that other inhalation agents and the incidence is up to 80%. Therefore, lower minimum alveolar concentration of sevoflurane will reduce the EA when it is used with remifentanil in pediatric general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Bundang Hospital
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• American Society of Anesthesiologist physical status I or II

• 2-6 year-old children

• patients undergoing tonsillectomy and adenoidectomy

Exclusion Criteria:

• upper respiratory disease

• mental retardation